Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05525390 · ClinicalTrials.gov registry record · NA

Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder

A NA study of Depression and Major Depressive Disorder, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT05525390 is a NA study of Depression and Major Depressive Disorder that has completed, run by Stanford University. The registered enrollment target is 26 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05525390, a NA study of Depression and Major Depressive Disorder, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The primary aims of this study are to assess the feasibility, acceptability, and tolerability of using an immersive extended reality (XR) headset to engage in behavioral activation (BA) for individuals diagnosed with major depressive disorder (MDD). The secondary aim of this study is to explore the efficacy of using XR to enhance BA therapy in a clinical MDD population.

Interventions

  • BEHAVIORAL Extended Reality-Enhanced Behavioral Activation
  • BEHAVIORAL Traditional Behavioral Activation

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2022-12-19
Est. Completion 2023-07-24
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05525390

The ClinicalTrials.gov registry entry for NCT05525390 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Extended Reality-Enhanced Behavioral Activation is the first listed.

NCT05525390 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05525390 about?

NCT05525390 is a clinical study titled "Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder". The primary aims of this study are to assess the feasibility, acceptability, and tolerability of using an immersive extended reality (XR) headset to engage in behavioral activation (BA) for individuals diagnosed with major depressive disorder (MDD). The secondary aim of this study is to explore the ...

What is the current status of trial NCT05525390?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-12-19. Estimated completion is 2023-07-24.

What conditions does trial NCT05525390 study?

This clinical trial studies the following conditions: Depression, Major Depressive Disorder, MDD.

What interventions are being tested in trial NCT05525390?

The interventions under investigation include: Extended Reality-Enhanced Behavioral Activation (BEHAVIORAL), Traditional Behavioral Activation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05525390?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05525390 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.